Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Language
Publication year range
1.
An Bras Dermatol ; 94(4): 462-469, 2019.
Article in English | MEDLINE | ID: mdl-31644623

ABSTRACT

Cutaneous mucinoses are a heterogeneous group of dermatoses in which excess deposition of mucin in the dermis gives the skin a waxy appearance, with papules and plaques that can vary from self-healing mucinosis to even disrupting the normal shape of a patient's face, conferring a leonine facies, or be part of life threatening diseases like scleromyxedema. This review will describe the most recent classification on lichen myxedematosus in the generalized (scleromyxedema) and the localized forms, as well as the different organ systems involved in scleromyxedema, diagnostic workup, current management, and prognosis.


Subject(s)
Scleromyxedema/diagnosis , Scleromyxedema/pathology , Skin Diseases/diagnosis , Skin Diseases/pathology , Fibroblasts/pathology , Humans , Mucins , Scleromyxedema/classification , Scleromyxedema/therapy , Skin/pathology , Skin Diseases/classification , Skin Diseases/therapy
2.
An. bras. dermatol ; 94(4): 462-469, July-Aug. 2019. tab, graf
Article in English | LILACS | ID: biblio-1038307

ABSTRACT

Abstract: Cutaneous mucinoses are a heterogeneous group of dermatoses in which excess deposition of mucin in the dermis gives the skin a waxy appearance, with papules and plaques that can vary from self-healing mucinosis to even disrupting the normal shape of a patient's face, conferring a leonine facies, or be part of life threatening diseases like scleromyxedema. This review will describe the most recent classification on lichen myxedematosus in the generalized (scleromyxedema) and the localized forms, as well as the different organ systems involved in scleromyxedema, diagnostic workup, current management, and prognosis.


Subject(s)
Humans , Skin Diseases/diagnosis , Skin Diseases/pathology , Scleromyxedema/diagnosis , Scleromyxedema/pathology , Skin/pathology , Skin Diseases/classification , Skin Diseases/therapy , Scleromyxedema/classification , Scleromyxedema/therapy , Fibroblasts/pathology , Mucins
3.
An Bras Dermatol ; 91(3): 336-43, 2016.
Article in English | MEDLINE | ID: mdl-27438202

ABSTRACT

Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplants (allo-HSCT) associated with significant morbidity and mortality. The earliest and most common manifestation is cutaneous graft-versus-host disease. This review focuses on the pathophysiology, clinical features, prevention and treatment of cutaneous graft-versus-host disease. We discuss various insights into the disease's mechanisms and the different treatments for acute and chronic skin graft-versus-host disease.


Subject(s)
Graft vs Host Disease/etiology , Hematopoietic Stem Cell Transplantation/adverse effects , Skin Diseases/etiology , Chronic Disease , Exanthema/etiology , Exanthema/therapy , Glucocorticoids/therapeutic use , Graft vs Host Disease/therapy , Humans , Photopheresis/methods , Skin Diseases/therapy
4.
An. bras. dermatol ; 91(3): 336-343, tab, graf
Article in English | LILACS | ID: lil-787293

ABSTRACT

Abstract Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplants (allo-HSCT) associated with significant morbidity and mortality. The earliest and most common manifestation is cutaneous graft-versus-host disease. This review focuses on the pathophysiology, clinical features, prevention and treatment of cutaneous graft-versus-host disease. We discuss various insights into the disease's mechanisms and the different treatments for acute and chronic skin graft-versus-host disease.


Subject(s)
Humans , Skin Diseases/etiology , Hematopoietic Stem Cell Transplantation/adverse effects , Graft vs Host Disease/etiology , Skin Diseases/therapy , Chronic Disease , Photopheresis/methods , Exanthema/etiology , Exanthema/therapy , Glucocorticoids/therapeutic use , Graft vs Host Disease/therapy
5.
Indian Dermatol Online J ; 5(2): 160-3, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24860751

ABSTRACT

Basal cell carcinomas (BCC) on the genital area account for less than 1% of all BCCs. Surgical management is indicated. Recurrence rate of vulvar BCC has been reported to be 10-20%. Mohs micrographic surgery (MMS) is a superior surgical option. Other treatments include radiation and topical immuntherapy. Cryosurgery for vulvar BCC has not been reported. We present the case of a 88-year-old Hispanic woman with a vulvar ulcer that was confirmed as BCC by histopathology and treated with liquid nitrogen cryosurgery. Control biopsy was performed on day 90 was negative for BCC. No clinical evidence of recurrence was detected after one year. Although, the vulva is considered to be a high-risk site with respect to BCC and MMS is the gold standard for treatment, the delicate nature of the area may preclude complete removal by a surgical technique without compromising vital anatomical function. Liquid nitrogen cryosurgery uses the effects of extreme cold to effect deep destruction of the tumor and surrounding tissues. This is the first report of a vulvar BCC successfully treated with liquid nitrogen cryosurgery. We suggest this technique could be of benefit as an alternative treatment in cases where excisional procedures cannot be performed.

SELECTION OF CITATIONS
SEARCH DETAIL
...